Related Experiment Videos

Theophylline pharmacokinetics in well-nourished and malnourished asthmatic children

L Kumar1, S K Garg, S Singh

  • 1Department of Pediatrics, Postgraduate Institute of Medical Education & Research, Chandigarh, India.

International Journal of Clinical Pharmacology, Therapy, and Toxicology
|December 1, 1989
PubMed

Insights

This study found that age, sex, and nutritional status do not significantly impact theophylline pharmacokinetics in children with asthma. However, a notable 5-fold variation in peak theophylline levels was observed between individuals.

Area of Science:

  • Pediatric Pharmacology
  • Clinical Pharmacy
  • Respiratory Medicine

Background:

  • Theophylline is a bronchodilator used in asthma management.
  • Understanding its pharmacokinetic variability in children is crucial for effective dosing.
  • Factors like age, sex, and nutritional status may influence drug metabolism and elimination.

Purpose of the Study:

  • To investigate the influence of age, sex, and nutritional status on theophylline pharmacokinetics in stable pediatric asthmatic patients.
  • To identify key factors affecting theophylline drug levels in children.

Main Methods:

  • A single oral dose of theophylline (6 mg/kg) was administered to stable asthmatic children on an empty stomach.
  • Plasma concentrations of theophylline were measured and pharmacokinetic parameters were calculated.
  • Patients were stratified into three pediatric age groups, and data were analyzed for differences based on age, sex, and nutritional status.

Main Results:

  • No significant differences in elimination half-life (t1/2), volume of distribution (Vd), clearance (cl), or area under the curve (AUC) were found across pediatric age groups.
  • Sex and nutritional status did not significantly influence theophylline pharmacokinetic parameters.
  • A significant 5-fold interindividual variability in peak plasma concentration (Cmax) was observed after a single dose.

Conclusions:

  • Age, sex, and nutritional status are not primary determinants of theophylline pharmacokinetics in stable asthmatic children.
  • Interindividual variability in peak theophylline concentrations is substantial and warrants further investigation for personalized dosing strategies.
  • These findings suggest that routine pharmacokinetic monitoring may be necessary to optimize theophylline therapy in pediatric asthma.

Related Concept Videos